European patent for AppDx® smartphone reader

Summary by AI BETAClose X

Abingdon Health plc has announced the granting of a new European patent, EP4150565, for its AppDx® lateral flow smartphone reader, following recent patent grants in the USA and UK. This AppDx® technology is a software development kit that utilizes smartphone cameras and deep learning algorithms to read colorimetric lateral-flow tests, enabling qualitative and semi-quantitative results. The company views this as a valuable tool for its contract development and manufacturing customers, highlighting ongoing innovation in the lateral flow market.

Disclaimer*

UK 100

Latest directors dealings